Verastem (VSTM) Depreciation and Depletion (2016 - 2025)
Verastem's quarterly Depreciation and Depletion came in at $18000.0 in Q4 2025, up 157.14% year-on-year from $7000.0 in Q4 2024, and up 800.0% quarter-over-quarter from $2000.0 in Q3 2025.
Verastem has reported Depreciation and Depletion for 10 years, with the latest figure at $18000.0 in Q4 2025.
- For the quarter ending Q4 2025, Depreciation and Depletion rose 157.14% year-over-year to $18000.0; the trailing twelve-month figure through Dec 2025 stood at $30000.0 (up 20.0% YoY), and the FY2025 full-year result was $30000.0, up 15.38% from the prior year.
- Depreciation and Depletion for Q4 2025 stood at $18000.0, up from $2000.0 in the prior quarter.
- The five-year high for Depreciation and Depletion was $81000.0 in Q1 2021, with the low at $2000.0 in Q3 2025.
- Average Depreciation and Depletion over 5 years is $22263.2, with a median of $18000.0 recorded in 2025.
- Year-over-year, Depreciation and Depletion sank 88.51% in 2021 and jumped 157.14% in 2025.
- Tracing VSTM's Depreciation and Depletion over 5 years: stood at $30000.0 in 2021, then plunged by 63.33% to $11000.0 in 2022, then slumped by 54.55% to $5000.0 in 2023, then soared by 40.0% to $7000.0 in 2024, then jumped by 157.14% to $18000.0 in 2025.
- The last three Depreciation and Depletion figures came in at $18000.0 (Q4 2025), $2000.0 (Q3 2025), and $10000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Verastem | 425.60 Mn | 243.93 Mn | 15.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Dec 31, 2025 | 18,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Mar 31, 2025 | 10,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Sep 30, 2023 | 5,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Mar 31, 2023 | 30,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Sep 30, 2022 | 30,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Jun 30, 2022 | 29,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Mar 31, 2022 | 30,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Sep 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Jun 30, 2021 | 65,000.00 |
| Mar 31, 2021 | 81,000.00 |
| Mar 31, 2021 | 81,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Dec 31, 2020 | 50,000.00 |
| Sep 30, 2020 | 261,000.00 |
| Sep 30, 2020 | 261,000.00 |
| Jun 30, 2020 | 95,000.00 |
| Jun 30, 2020 | 95,000.00 |
| Mar 31, 2020 | 94,000.00 |
| Mar 31, 2020 | 94,000.00 |
| Dec 31, 2019 | 65,000.00 |
| Dec 31, 2019 | 65,000.00 |
| Sep 30, 2019 | 108,000.00 |
| Sep 30, 2019 | 108,000.00 |
| Jun 30, 2019 | 114,000.00 |
| Jun 30, 2019 | 114,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Mar 31, 2019 | 113,000.00 |
| Dec 31, 2018 | 108,000.00 |
| Dec 31, 2018 | 108,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | 667,000.00 |
| Jun 30, 2018 | 667,000.00 |
| Mar 31, 2018 | 125,000.00 |
| Mar 31, 2018 | 125,000.00 |
| Dec 31, 2017 | 172,000.00 |
| Dec 31, 2017 | 172,000.00 |
| Sep 30, 2017 | 138,000.00 |
| Sep 30, 2017 | 138,000.00 |
| Jun 30, 2017 | 144,000.00 |
| Jun 30, 2017 | 144,000.00 |
| Mar 31, 2017 | 146,000.00 |
| Mar 31, 2017 | 146,000.00 |
| Dec 31, 2016 | 152,000.00 |
| Dec 31, 2016 | 152,000.00 |
| Sep 30, 2016 | 159,000.00 |
| Sep 30, 2016 | 159,000.00 |
| Jun 30, 2016 | 176,000.00 |
| Jun 30, 2016 | 176,000.00 |
| Mar 31, 2016 | 183,000.00 |
| Mar 31, 2016 | 183,000.00 |